Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Willis Towers Watson Plc stacks up to the competition and put relevant competitor and industry information at your fingertips.
Acclaris Holdings, Brovada Technologies, Extend Health, Gras Savoye, Risk Capital Advisors, Tranzact, Willis
Willis Towers Watson is a public company headquartered in United Kingdom with an estimated 48,000 employees. In the US, the company has a notable market share in at least three industries: HR Consulting, Risk Management, Insurance Advisory & Consulting, Claims Adjusting and Claims Adjusting. Their largest market share is in the Claims Adjusting industry, where they account for an estimated 44.9% of total industry revenue and are considered a Disruptor because they display lower to medium market share that’s rising rapidly, but weaker profits compared to some of their peers.
Of the 5 core revenue-generating products and services in the Claims Adjusting industry, Willis Towers Watson Plc offers:
Of the 4 core revenue-generating products and services in the Risk Management, Insurance Advisory & Consulting industry, Willis Towers Watson Plc offers:
Of the 4 core revenue-generating products and services in the HR Consulting industry, Willis Towers Watson Plc offers:
Strengths and weaknesses take into account internal factors, and are based on Willis Towers Watson Plc's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Claims Adjusting , Risk Management, Insurance Advisory & Consulting , HR Consulting industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Revenue | 8,513.0 | 8,370.0 | 8,615.0 | 8,998.0 | 8,866.0 | 9,483.0 |
Cost of Revenue | ||||||
Cost of Revenue, Non-Cash | ||||||
Gross Profit | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Cash and Equivalents | 1,033.0 | 887.0 | 2,039.0 | 4,486.0 | 1,262.0 | 1,424.0 |
Short-Term Investments | ||||||
Derivative Assets, Current | ||||||
Restricted Cash and Investments | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Net Income | 715.0 | 1,073.0 | 1,020.0 | 4,236.0 | 1,024.0 | 1,064.0 |
Income (Loss) From Discontinued Operations | ||||||
Depreciation, Depletion and Amortization | ||||||
Amortization of Financing Costs and Discounts | ||||||
00000 |
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.